NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CBUS

Cibus Inc

Jun 30 • 04:00PM ET

1.38

Dollar change -0.03
Percentage change -2.13	%

Healthcare • Biotechnology • USA • NASD

Peers: ADM BG TSN BYND DAR INGR AGRO CALM FDP SANW

| Held by: VTI VXF VTWO IWM IWC IWN VTWV MSSM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-10.93	Insider Own	39.12%	Shs Outstand	32.66M	Perf Week	-8.61%
Market Cap	69.14M	Forward P/E	-	EPS next Y	-1.60	Insider Trans	-0.22%	Shs Float	29.46M	Perf Month	-55.34%
Enterprise Value	292.69M	PEG	-	EPS next Q	-0.60	Inst Own	24.97%	Short Float	6.28%	Perf Quarter	-32.35%
Income	-274.84M	P/S	14.56	EPS this Y	76.29%	Inst Trans	26.41%	Short Ratio	4.74	Perf Half Y	-51.41%
Sales	4.75M	P/B	0.64	EPS next Y	37.85%	ROA	-63.32%	Short Interest	1.85M	Perf YTD	-50.36%
Book/sh	2.15	P/C	2.93	EPS next 5Y	50.67%	ROE	-157.73%	52W High	10.77 -87.19%	Perf Year	-84.67%
Cash/sh	0.47	P/FCF	-	EPS past 3/5Y	34.74% 29.09%	ROIC	-88.99%	52W Low	1.40 -1.43%	Perf 3Y	-91.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-45.26% -10.19%	Gross Margin	-39.87%	Volatility	9.95% 11.20%	Perf 5Y	-99.50%
Dividend TTM	-	EV/Sales	61.62	EPS Y/Y TTM	40.41%	Oper. Margin	-1665.59%	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.23	Sales Y/Y TTM	104.78%	Profit Margin	-5784.87%	RSI (14)	35.38	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.23	EPS Q/Q	-19.08%	SMA20	-23.17%	Beta	1.73	Target Price	16.38
Payout	-	Debt/Eq	3.46	Sales Q/Q	89.72%	SMA50	-34.93%	Rel Volume	1.16	Prev Close	1.41
Employees	159	LT Debt/Eq	3.40	Earnings	May 08 AMC	SMA200	-52.11%	Avg Volume	390.14K	Price	1.38
IPO	Jul 20, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-129.73% -9.30%	Trades		Volume	452,301	Change	-2.13%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-29-24	Initiated	Alliance Global Partners	Buy	$25
Jul-19-24	Resumed	Canaccord Genuity	Buy	$22
Oct-09-23	Initiated	H.C. Wainwright	Buy	$25
Jul-19-23	Resumed	Canaccord Genuity	Buy	$30

Jun-24-25 07:00AM	The U.S. Food and Drug Administration Completes Review of Cibus' Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed (GlobeNewswire)
Jun-12-25 08:00AM	Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming (GlobeNewswire)
Jun-09-25 08:22PM	Cibus, Inc. Announces Closing of $27.5 Million Public Offering (GlobeNewswire)
Jun-07-25 09:30AM	Cibus says USDA designates HT2 as not regulated under biotech regulations (TipRanks)
Jun-06-25 09:26AM	USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations (GlobeNewswire) +7.10%
08:30AM	Loading…
Jun-05-25 08:30AM	Cibus, Inc. Announces Pricing of $27.5 Million Public Offering (GlobeNewswire) -34.32%
Jun-04-25 04:19PM	Cibus, Inc. Announces Proposed Public Offering (GlobeNewswire) -15.71%
May-27-25 07:00AM	Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat (GlobeNewswire) +12.65%
May-19-25 04:05PM	Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase (GlobeNewswire) +10.64% -9.46%
May-08-25 06:25PM	Cibus (CBUS) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -6.00% -8.72%
04:05PM	Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025 (GlobeNewswire)
May-07-25 07:00AM	Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding (GlobeNewswire) +20.77%
May-06-25 10:00AM	Will Cadiz (CDZI) Report Negative Q1 Earnings? What You Should Know (Zacks)
May-01-25 10:01AM	Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 06:30PM	Matthews International (MATW) Lags Q2 Earnings and Revenue Estimates (Zacks) +9.69%
07:00AM	Loading…
Apr-25-25 07:00AM	Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call (GlobeNewswire)
Apr-24-25 09:00AM	USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated (GlobeNewswire) +6.42%
Mar-21-25 03:05AM	Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights (GuruFocus.com) -6.39%
Mar-20-25 07:31PM	Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026 (SeekingAlpha) -7.59%
07:31PM	Cibus, Inc. (CBUS) Q4 2024 Earnings Call Transcript (SeekingAlpha)
04:05PM	Cibus Reports Fourth Quarter Financial Results and Provides Business Update (GlobeNewswire)
Mar-17-25 07:00AM	Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward (GlobeNewswire) +8.18%
Mar-11-25 07:00AM	Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call (GlobeNewswire)
Mar-04-25 09:15AM	Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola (GlobeNewswire)
Feb-28-25 08:30AM	Cibus Announces Leadership Change and CEO Succession Plan (GlobeNewswire) +7.33%
Feb-14-25 07:00AM	Cibus Announces Important Update to Rice Gene Editing Conversion Rates (GlobeNewswire)
Jan-28-25 08:00AM	Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer (GlobeNewswire)
Jan-22-25 04:05PM	Cibus to Participate in the Sidoti Micro Cap Conference (GlobeNewswire) +11.11%
Jan-21-25 09:00AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE) -5.65%
08:30AM	Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq's Minimum Price in Accordance with Nasdaq Rules (GlobeNewswire)
07:00AM	Loading…
Jan-16-25 07:00AM	Cibus' Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits (GlobeNewswire) -9.19%
Dec-17-24 07:20AM	Cibus, Albaugh, RTDC affirm collaboration for weed management solution (TipRanks)
Dec-16-24 07:00AM	Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers (GlobeNewswire)
Nov-19-24 07:30AM	Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape (GlobeNewswire)
Nov-18-24 07:00AM	Cibus to Participate in the 13th Annual Roth Technology Conference (GlobeNewswire) -7.06%
Nov-14-24 07:00AM	Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola (GlobeNewswire)
Nov-10-24 08:00AM	Cibus Inc (CBUS) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Nov-07-24 04:05PM	Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024 (GlobeNewswire) +19.89%
Nov-06-24 07:49AM	Cibus Inc (CBUS) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-05-24 08:00AM	Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola (GlobeNewswire) +7.45%
Oct-24-24 07:00AM	Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call (GlobeNewswire)
Oct-21-24 07:00AM	Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities (GlobeNewswire)
Oct-11-24 08:49AM	Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress (GlobeNewswire) +16.72%
Sep-23-24 01:01PM	Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly (GlobeNewswire) -11.12%
Sep-18-24 08:25AM	Cibus Announces Pricing of Public Offering of Class A Common Stock (GlobeNewswire) -28.95%
Sep-17-24 04:46PM	Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock (GlobeNewswire)
Sep-10-24 07:00AM	Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape (GlobeNewswire) +9.35%
Aug-12-24 04:05PM	Cibus to Participate in Upcoming August Investor Events (GlobeNewswire) +8.77%
Aug-08-24 04:05PM	Cibus Reports Second Quarter Financial Results and Provides First Half Business Update (GlobeNewswire) -5.90%
Aug-06-24 07:36AM	Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice (GlobeNewswire)
Aug-01-24 07:00AM	Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call (GlobeNewswire) -7.38%
Jun-26-24 08:30AM	Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits (GlobeNewswire)
Jun-17-24 07:00AM	Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development (GlobeNewswire)
Jun-12-24 08:00AM	Cibus Announces $13.0 Million Registered Direct Offering (GlobeNewswire)
Jun-05-24 07:00AM	Cibus to Participate in Upcoming June Investor Events (GlobeNewswire)
May-30-24 07:00AM	Cibus' White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola (GlobeNewswire)
May-15-24 07:00AM	Canada Added to a Growing List of Countries Regulating Cibus' Gene Editing Technologies Similar to Conventional Breeding (GlobeNewswire)
May-13-24 07:00AM	Cibus to Participate in the BMO Global Farm to Market Conference (GlobeNewswire) +5.69%
May-09-24 10:55PM	CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Cibus Reports First Quarter Financial Results and Provides Business Update (GlobeNewswire)
Apr-25-24 07:00AM	Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call (GlobeNewswire)
Mar-25-24 03:16PM	Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates (Revised) (Zacks) +5.25%
Mar-22-24 01:03PM	Cibus, Inc. (NASDAQ:CBUS) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.10%
Mar-21-24 08:52PM	CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -9.01%
04:05PM	Cibus Reports Fourth Quarter Financial Results and Provides Business Update (GlobeNewswire)
Mar-19-24 08:30AM	Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (GlobeNewswire) -6.80%
Mar-18-24 08:26AM	Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last? (Zacks) +5.13%
Mar-13-24 07:35AM	Cibus to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Mar-07-24 07:00AM	Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call (GlobeNewswire)
Feb-26-24 07:00AM	Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US (GlobeNewswire)
Feb-07-24 12:51PM	European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques (GlobeNewswire)
Jan-25-24 04:30PM	European Parliaments Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques (GlobeNewswire)
Jan-17-24 07:00AM	Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales (GlobeNewswire)
Jan-09-24 07:00AM	Cibus Announces Major Breakthrough in Wheat Regeneration from Single Cells (GlobeNewswire) +6.27%
Jan-04-24 07:30AM	Cibus Enters into a Latin America Collaboration Agreement with Interoc to deliver rice growers an innovative rice weed control system (GlobeNewswire)
Dec-12-23 07:30AM	Cibus Announces $20.3 Million Registered Direct Offering (GlobeNewswire)
Dec-01-23 08:00AM	European Union Notifies Trading Partners on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire) +10.34%
Nov-30-23 08:00AM	Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus (GlobeNewswire)
Nov-09-23 04:05PM	Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +19.76%
Nov-06-23 08:00AM	European Parliament Releases Draft Report on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire)
Nov-02-23 04:05PM	Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call (GlobeNewswire)
Oct-09-23 09:33AM	Oracle upgraded, Spotify downgraded: Wall Street's top analyst calls (The Fly) -8.67%
Sep-18-23 05:23PM	Jim Collins to Join Cibus Board of Directors (GlobeNewswire) +15.85%
Sep-05-23 08:00AM	Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) +11.27%
Aug-09-23 05:00PM	Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -7.76%
Aug-03-23 12:30PM	Steve Berreth Appointed as General Counsel and Corporate Secretary (GlobeNewswire) +5.33%
07:00AM	Cibus to Report Second Quarter 2023 Financial Results on August 10, 2023 and Host Conference Call (GlobeNewswire)
Aug-02-23 04:05PM	Cibus to Present at the Canaccord 43rd Annual Growth Conference (GlobeNewswire)
Jul-12-23 08:30AM	Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production (GlobeNewswire)
Jul-05-23 04:05PM	Cibus Welcomes European Commission Proposal on Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire) +26.93% +22.32%
Jun-15-23 08:45AM	Cibus Applauds the Genetic Technology (Precision Breeding) Act 2023 Passed in the United Kingdom (GlobeNewswire) +10.78%
07:00AM	Cibus to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jun-07-23 07:00AM	Cibus White Mold Resistance Trait in Canola Achieves Another Important Milestone (GlobeNewswire)
Jun-01-23 07:00AM	Cibus Announces Closing of Merger with Calyxt to Create Industry Leading Precision Gene Editing and Trait Development Company (GlobeNewswire) -17.30%

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded by Rory Riggs, Peter Beetham and Greg Gocal in 2001 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Prante Gerhard	Director	Feb 25 '25	Sale	1.92	1,150	2,208	7,707	Feb 26 06:25 PM
Prante Gerhard	Director	Feb 24 '25	Sale	2.07	1,150	2,380	8,857	Feb 25 04:45 PM
Prante Gerhard	Director	Feb 21 '25	Sale	2.20	1,150	2,530	10,007	Feb 24 02:51 PM
Prante Gerhard	Director	Feb 20 '25	Sale	2.35	1,150	2,702	11,157	Feb 21 03:45 PM
Prante Gerhard	Director	Feb 19 '25	Sale	2.58	1,150	2,967	12,307	Feb 20 03:51 PM
Prante Gerhard	Director	Feb 18 '25	Sale	2.52	2,300	5,796	13,457	Feb 19 03:37 PM
Prante Gerhard	Director	Feb 14 '25	Sale	2.60	1,150	2,990	15,757	Feb 18 03:10 PM
Prante Gerhard	Director	Feb 13 '25	Sale	2.53	1,150	2,910	16,907	Feb 14 04:25 PM
Prante Gerhard	Director	Feb 12 '25	Sale	2.45	1,150	2,818	18,057	Feb 13 04:27 PM
Prante Gerhard	Director	Feb 11 '25	Sale	2.48	1,150	2,852	19,207	Feb 12 04:10 PM
Prante Gerhard	Director	Feb 10 '25	Sale	2.52	1,150	2,898	20,357	Feb 11 03:39 PM
Prante Gerhard	Director	Feb 07 '25	Sale	2.50	1,150	2,875	21,507	Feb 10 03:48 PM
Prante Gerhard	Director	Feb 06 '25	Sale	2.55	1,150	2,932	22,657	Feb 07 04:37 PM
Prante Gerhard	Director	Feb 05 '25	Sale	2.52	1,150	2,898	23,807	Feb 06 04:21 PM
Prante Gerhard	Director	Feb 04 '25	Sale	2.45	1,150	2,818	24,957	Feb 05 03:24 PM
Prante Gerhard	Director	Feb 03 '25	Sale	2.41	1,150	2,772	26,107	Feb 04 04:25 PM
Prante Gerhard	Director	Jan 31 '25	Sale	2.55	1,150	2,932	27,257	Feb 03 04:14 PM
Prante Gerhard	Director	Jan 30 '25	Sale	2.46	1,150	2,829	28,407	Jan 31 04:15 PM
Prante Gerhard	Director	Jan 29 '25	Sale	2.42	1,150	2,783	29,557	Jan 30 04:38 PM
Prante Gerhard	Director	Jan 28 '25	Sale	2.44	1,150	2,806	30,707	Jan 29 04:52 PM
Prante Gerhard	Director	Jan 27 '25	Sale	2.37	1,150	2,726	31,857	Jan 28 04:46 PM
Prante Gerhard	Director	Jan 24 '25	Sale	2.60	1,150	2,990	33,007	Jan 27 03:57 PM
Prante Gerhard	Director	Jan 23 '25	Sale	2.59	1,150	2,978	34,157	Jan 24 04:15 PM
Prante Gerhard	Director	Jan 21 '25	Sale	2.50	1,150	2,875	36,457	Jan 23 04:44 PM
Prante Gerhard	Director	Jan 22 '25	Sale	2.31	1,150	2,656	35,307	Jan 23 04:44 PM
Prante Gerhard	Director	Jan 21 '25	Sale	2.50	1,150	2,875	37,607	Jan 22 03:09 PM
Prante Gerhard	Director	Jan 17 '25	Sale	2.50	1,150	2,875	38,757	Jan 21 04:36 PM
Prante Gerhard	Director	Jan 16 '25	Sale	2.75	1,150	3,162	39,907	Jan 17 03:28 PM
Prante Gerhard	Director	Jan 15 '25	Sale	2.56	1,150	2,944	41,057	Jan 17 03:28 PM
Prante Gerhard	Director	Jan 14 '25	Sale	2.42	1,150	2,783	42,207	Jan 15 03:59 PM
Prante Gerhard	Director	Jan 13 '25	Sale	2.34	1,150	2,691	43,357	Jan 14 03:34 PM
Prante Gerhard	Director	Jan 10 '25	Sale	2.57	2,300	5,911	44,507	Jan 13 03:48 PM
Prante Gerhard	Director	Jan 08 '25	Sale	2.80	1,150	3,220	46,807	Jan 10 09:57 AM
Prante Gerhard	Director	Jan 07 '25	Sale	3.06	1,150	3,519	47,957	Jan 08 03:19 PM
Prante Gerhard	Director	Jan 06 '25	Sale	3.14	1,150	3,611	49,107	Jan 07 03:26 PM
Prante Gerhard	Director	Jan 03 '25	Sale	2.89	1,150	3,324	50,257	Jan 07 03:26 PM
Prante Gerhard	Director	Dec 19 '24	Sale	3.45	1,150	3,968	51,407	Dec 20 05:36 PM
Prante Gerhard	Director	Dec 18 '24	Sale	3.75	1,150	4,312	52,557	Dec 19 06:09 PM
Prante Gerhard	Director	Dec 16 '24	Sale	4.06	1,150	4,669	54,857	Dec 18 04:50 PM
Prante Gerhard	Director	Dec 17 '24	Sale	3.85	1,150	4,428	53,707	Dec 18 04:50 PM
Prante Gerhard	Director	Dec 13 '24	Sale	3.87	1,150	4,450	56,007	Dec 16 04:32 PM
Prante Gerhard	Director	Dec 12 '24	Sale	4.08	1,150	4,692	57,157	Dec 13 03:36 PM
Prante Gerhard	Director	Dec 11 '24	Sale	4.35	1,150	5,002	58,307	Dec 12 04:16 PM
Prante Gerhard	Director	Dec 10 '24	Sale	4.43	1,150	5,094	59,457	Dec 11 04:10 PM
Prante Gerhard	Director	Dec 09 '24	Sale	4.15	1,150	4,772	60,607	Dec 10 04:04 PM
Prante Gerhard	Director	Dec 06 '24	Sale	3.86	1,150	4,439	61,757	Dec 09 03:36 PM
Prante Gerhard	Director	Dec 05 '24	Sale	4.00	1,150	4,600	62,907	Dec 06 04:05 PM
Prante Gerhard	Director	Dec 04 '24	Sale	4.39	1,150	5,048	64,057	Dec 05 03:43 PM
Prante Gerhard	Director	Dec 03 '24	Sale	4.69	1,150	5,394	65,207	Dec 04 03:32 PM
Prante Gerhard	Director	Dec 02 '24	Sale	4.46	2,300	10,258	66,357	Dec 03 03:15 PM
Prante Gerhard	Director	Nov 27 '24	Sale	4.50	1,150	5,175	68,657	Dec 02 05:11 PM
Prante Gerhard	Director	Nov 26 '24	Sale	4.57	1,150	5,256	69,807	Nov 27 02:43 PM
Prante Gerhard	Director	Nov 25 '24	Sale	4.19	1,150	4,818	70,957	Nov 26 03:14 PM
Prante Gerhard	Director	Nov 22 '24	Sale	4.32	1,150	4,968	72,107	Nov 25 04:33 PM
Prante Gerhard	Director	Nov 20 '24	Sale	4.30	1,150	4,945	74,407	Nov 22 01:47 PM
Prante Gerhard	Director	Nov 21 '24	Sale	4.03	1,150	4,634	73,257	Nov 22 01:47 PM
Prante Gerhard	Director	Nov 18 '24	Sale	4.53	1,150	5,210	76,707	Nov 20 02:09 PM
Prante Gerhard	Director	Nov 19 '24	Sale	4.12	1,150	4,738	75,557	Nov 20 02:09 PM
Prante Gerhard	Director	Nov 18 '24	Proposed Sale	4.78	71,785	343,132		Nov 18 09:32 AM
Broos Carlo	Interim CFO	Nov 12 '24	Sale	5.30	4,647	24,629	74,197	Nov 13 02:12 PM
Gocal Gregory Francis William	Chief Scientific Officer & EVP	Jul 15 '24	Sale	10.01	2,000	20,023	314,844	Jul 17 04:10 PM
Gocal Gregory Francis William	Chief Scientific Officer & EVP	Jul 12 '24	Sale	10.00	2,000	20,000	316,844	Jul 15 05:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CBUS

Cibus Inc

Upgrade your FINVIZ experience